The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.
Dr Jonathan Kentley: Physicians Are Working Alongside AI, Not Being Replaced by ItJune 30th 2022
Jonathan Kentley, MBBS, MSc, research fellow at Memorial Sloan Kettering Cancer Center, talks about how dermatologists are working with artificial intelligence (AI) while still making sure patient voices are heard.
Researchers Outline Use of Hormonal Therapies in Acne, Hidradenitis SuppurativaJune 25th 2022
Combined oral contraceptives (COCs) and, more recently, spironolactone, have been identified as options for adolescent females with acne and hidradenitis suppurativa (HS), although varying levels of data are available supporting their use in these patients.
What We’re Reading: FDA Approves Alopecia Drug; AMA Opposes Abortion Restrictions; Experimental ALS TherapyJune 14th 2022
The FDA approved Eli Lilly’s baricitinib drug to regrow hair in patients with alopecia; the American Medical Association (AMA) adopts resolutions that go against criminalization of abortion; an experimental amyotrophic lateral sclerosis (ALS) therapy under review with the FDA has been approved in Canada.
Increases in Inflammatory Markers, Leukocyte Profile May Impact HS SeverityMay 20th 2022
The findings come from a novel longitudinal analysis of 400 patients, which the researchers said validates and further underscores the utility of laboratory parameters for the management of hidradenitis suppurativa.
New Study Points to Inflammation-Based Biomarker Associated With HS SeverityMay 7th 2022
According to the researchers of this new study, the biomarker may have potential for use with clinical scores in treatment decisions or in clinical trials that focus on hidradenitis suppurativa (HS).
Study Shows High Level of Gaps in Care Needs Among Those With HSApril 21st 2022
Interviewing both patients and providers, researchers found that while having effective treatments for hidradenitis suppurativa (HS) took precedence across the board, some priorities varied among the 2 groups.
European Study Shows High Rate of Skin Conditions, DiseasesApril 8th 2022
When including patients who had a mole check or cancer screening, the proportion of patients with at least 1 dermatological condition or disease increased to 47%; both non-melanoma and melanoma skin cancers were among the top 12 skin diseases reported in the study.
Researchers Highlight Special Considerations for Managing HS in Certain PopulationsApril 2nd 2022
As potential new treatment options emerge for hidradenitis suppurativa (HS), an inflammatory condition, researchers emphasized the importance of clinicians being prepared to manage patients that have additional health factors.
Study Findings Signal Some PE-Backed Dermatology Practices May Not Be Performing WellMarch 18th 2022
Public financial statements from 9 dermatology groups backed by private equity (PE) were analyzed by the researchers, who described a significant decrease in debt valuations of these groups both before and during the COVID-19 pandemic.
Dose Reduction May Lower Hair Loss Frequency, Allow for Longer Use of Isotretinoin for AcneMarch 4th 2022
Data from 22 studies were collected on reported hair loss with isotretinoin treatment, showing a hair loss frequency of 3.2% for patients receiving <0.5 mg/kg/day and a frequency of 5.7% for patients receiving ≥0.5 mg/kg/day.